Default company panoramic image
184ce33a af3c 4013 b9e9 eebdd9b1355f

Chromatan Corporation

Enabling flexible and cost-saving manufacturing for life-saving biologic therapies.

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location Philadelphia, PA, USA
  • Currency USD
  • Founded January 2009
  • Employees 10
  • Incorporation Type C-corp
  • Website chromatan.com

Company Summary

Chromatan is commercializing a new purification platform to de-bottleneck large-scale manufacturing of life-saving biologics . We have shown up to 15-fold improvements and 65% cost reduction in multiple pilot studies with large biotechs like Merck and Regeneron.

In 2017 ChromaTan was awarded a $2.5 Million contract from the FDA. We are raising $1.1 Million to enable manufacturing, scale-up and sales of our process development system.

Team

  • Default avatar
    Oleg Shinkazh
    CEO

    Oleg Shinkazh, founder and CEO of ChromaTan and the inventor of Continuous Countercurrent Tangential Chromatography (CCTC) is a chemical and biotechnologyengineer with 17 years of experience in the biotechnology industry, specializing in downstream processing and purification of biologics. Oleg has been with ChromaTan since October 2009, leading technical and business development of the company.

  • Default avatar
    Boris Napadensky
    VP of Engineering

    Boris Napadensky, VP of Engineering at ChromaTan, is a chemical engineer with 18 years of experience in leading the development and scale-up of new technologies. Boris is an accomplished technical manager with extensive expertise in design and construction of new chemical process systems on lab, pilot and commercial scale. Boris has led ChromaTan’s design and construction efforts of since 2012.

  • Default avatar
    Dr. Andrew Zydney
    Board member

    Dr. Andrew Zydney is a Professor of Chemical Engineering at Penn State University. He is one of the leading researchers in the bioseparations industry, with more than 150 publications in leading industry journals. Dr. Zydney supervises the technical partnership of ChromaTan with Penn State, and has been an invaluable resource for the company.

  • Default avatar
    Paul H. Silvis
    Board Member

    Paul founded Restek (www.restek.com) in 1985 to manufacture innovative, high quality chromatography products. The company’s sales exceed $60 Million and continue to outpace competitors. Paul is ChromaTan's largest individual investor and has been an invaluable adviser as a member of the board of directors.

  • Default avatar
    Steve Carpenter
    Board Member

    Steve Carpenter is the Vice President of Venture Operations at the Life Sciences Greenhouse of Central Pennsylvania. The LSGPA provides investment and support to promising life sciences companies in central Pennsylvania. Since joining the LSGPA in 2004, Steve has served as a board observer or director for 10 startup companies while evaluating prospective companies for investment.

Advisors

Previous Investors

  • Default avatar
    Ben Franklin of Central PA $500,000
    Unconfirmed
    Default avatar
    Life Science Greenhouse of Central PA $600,000
    Unconfirmed
    Default avatar
    Series A commitment - Lehigh Valley Angels; $120,000
    Unconfirmed
  • Default avatar
    Series A commitment - Norman Sorensen Family office $350,000
    Unconfirmed